(Q46964965)

26 December 2017

title

Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer (English)

1 reference

26 December 2017

1 reference

Luke F M Hoagland

1

1 reference

26 December 2017

Michael J Campa

2

1 reference

26 December 2017

Elizabeth B Gottlin

3

1 reference

26 December 2017

James E Herndon

4

1 reference

26 December 2017

Edward F Patz

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

110

1 reference

26 December 2017

page(s)

2260-2268

1 reference

26 December 2017

issue

10

1 reference

26 December 2017

The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

Sialilated beta1,6 branched N-oligosaccharides modulate adhesion, chemotaxis and motility of melanoma cells: Effect on invasion and spontaneous metastasis properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

CT screening for lung cancer: five-year prospective experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Screening for lung cancer: a review of the current literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Screening for lung cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Computed tomography screening and lung cancer outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Molecular biology and early diagnosis in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

New approaches for biomarker discovery in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

In search of the holy grail: lung cancer biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Fucosylation of serum glycoproteins in lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

A novel function of haptoglobin: haptoglobin-haemoglobin complex induces apoptosis of hepatocarcinomatous Hep 3B cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

An improved ELISA for the determination of sialyl Lewis(x) structures on purified glycoconjugates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor Cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Differential expression of beta-galactoside alpha2,6 sialyltransferase and sialoglycans in normal and cirrhotic liver and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23049

7 January 2021

Identifiers

DOI

10.1002/CNCR.23049

1 reference

26 December 2017

PubMed ID

17918261

1 reference

26 December 2017